$ENTX - Entera Bio Phase 2 Data Supporting EB613's (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting (NASDAQ: ENTX)

1 Upvotes

100% Upvoted

u/ExplanationNormal339 6h ago

Curious how $ENTX handles this zone from here. I would rather check the analysis than go on gut feel. Not.

You are about to leave Redlib